| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insulin-Secreting Cells | 75 | 2023 | 898 | 12.440 |
Why?
|
| Islets of Langerhans | 174 | 2024 | 1349 | 12.170 |
Why?
|
| Islets of Langerhans Transplantation | 92 | 2024 | 746 | 10.150 |
Why?
|
| Diabetes Mellitus, Experimental | 78 | 2024 | 1118 | 6.000 |
Why?
|
| Insulin | 159 | 2024 | 6599 | 3.780 |
Why?
|
| Diabetes Mellitus, Type 1 | 28 | 2023 | 3446 | 2.660 |
Why?
|
| Glucose | 67 | 2023 | 4335 | 2.500 |
Why?
|
| Pancreas | 41 | 2017 | 1700 | 2.080 |
Why?
|
| Glucagon | 63 | 2023 | 533 | 2.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 42 | 2023 | 12240 | 1.800 |
Why?
|
| Hyperglycemia | 32 | 2020 | 1393 | 1.800 |
Why?
|
| Blood Glucose | 82 | 2023 | 6424 | 1.630 |
Why?
|
| Insulin Resistance | 14 | 2023 | 3985 | 1.370 |
Why?
|
| Alginates | 12 | 2018 | 247 | 1.330 |
Why?
|
| Pancreatic Ducts | 11 | 2015 | 332 | 1.300 |
Why?
|
| Rats | 147 | 2024 | 23707 | 1.260 |
Why?
|
| Capsules | 14 | 2020 | 193 | 1.220 |
Why?
|
| Transplantation, Heterologous | 22 | 2020 | 2394 | 1.100 |
Why?
|
| Diabetes Mellitus | 26 | 2021 | 5891 | 1.090 |
Why?
|
| Somatostatin | 42 | 2009 | 459 | 1.080 |
Why?
|
| Pancreatectomy | 30 | 2020 | 820 | 0.960 |
Why?
|
| Animals | 271 | 2024 | 168764 | 0.940 |
Why?
|
| Cell Transplantation | 5 | 2020 | 473 | 0.890 |
Why?
|
| Regeneration | 20 | 2017 | 1517 | 0.890 |
Why?
|
| Glucagon-Secreting Cells | 2 | 2023 | 42 | 0.880 |
Why?
|
| alpha 1-Antitrypsin | 2 | 2018 | 168 | 0.860 |
Why?
|
| Rats, Inbred Lew | 24 | 2020 | 1167 | 0.850 |
Why?
|
| Graft Survival | 19 | 2024 | 3890 | 0.850 |
Why?
|
| Microdissection | 6 | 2011 | 152 | 0.840 |
Why?
|
| Cell Size | 5 | 2013 | 625 | 0.830 |
Why?
|
| Hypoglycemia | 5 | 2023 | 896 | 0.810 |
Why?
|
| Monosaccharide Transport Proteins | 13 | 2002 | 437 | 0.790 |
Why?
|
| Rats, Sprague-Dawley | 48 | 2018 | 8102 | 0.770 |
Why?
|
| Pancreas Transplantation | 5 | 2016 | 194 | 0.670 |
Why?
|
| Transduction, Genetic | 4 | 2009 | 898 | 0.670 |
Why?
|
| Mice | 100 | 2024 | 81819 | 0.650 |
Why?
|
| Gene Expression Regulation | 20 | 2018 | 11888 | 0.630 |
Why?
|
| Cell Death | 6 | 2016 | 1679 | 0.620 |
Why?
|
| Transplantation, Heterotopic | 6 | 2011 | 175 | 0.620 |
Why?
|
| Cells, Immobilized | 1 | 2018 | 35 | 0.610 |
Why?
|
| Glucose Tolerance Test | 20 | 2018 | 1180 | 0.530 |
Why?
|
| Cell Dedifferentiation | 2 | 2014 | 125 | 0.520 |
Why?
|
| Trans-Activators | 12 | 2016 | 2850 | 0.520 |
Why?
|
| C-Peptide | 10 | 2018 | 443 | 0.510 |
Why?
|
| Cell Aggregation | 4 | 2010 | 238 | 0.510 |
Why?
|
| Oxidative Stress | 7 | 2014 | 3141 | 0.490 |
Why?
|
| Ki-67 Antigen | 2 | 2014 | 629 | 0.490 |
Why?
|
| Homeodomain Proteins | 12 | 2016 | 2428 | 0.490 |
Why?
|
| Cell Division | 19 | 2014 | 4475 | 0.480 |
Why?
|
| Venoms | 5 | 2013 | 94 | 0.480 |
Why?
|
| Adenoviridae | 10 | 2014 | 1092 | 0.480 |
Why?
|
| Stress, Physiological | 4 | 2019 | 1402 | 0.470 |
Why?
|
| Unfolded Protein Response | 1 | 2017 | 239 | 0.470 |
Why?
|
| Hydrogels | 5 | 2016 | 728 | 0.450 |
Why?
|
| Foreign-Body Reaction | 5 | 2023 | 153 | 0.450 |
Why?
|
| Mice, Inbred Strains | 13 | 2006 | 1770 | 0.440 |
Why?
|
| Streptozocin | 16 | 2013 | 189 | 0.430 |
Why?
|
| Animals, Newborn | 17 | 2014 | 2669 | 0.430 |
Why?
|
| Endothelial Growth Factors | 3 | 2001 | 680 | 0.420 |
Why?
|
| Proinsulin | 10 | 2023 | 135 | 0.420 |
Why?
|
| Incretins | 1 | 2014 | 100 | 0.410 |
Why?
|
| Lymphokines | 3 | 2001 | 911 | 0.410 |
Why?
|
| Maf Transcription Factors, Large | 4 | 2015 | 21 | 0.400 |
Why?
|
| Peptides | 12 | 2013 | 4331 | 0.400 |
Why?
|
| Mice, Inbred ICR | 2 | 2010 | 339 | 0.400 |
Why?
|
| I-kappa B Kinase | 1 | 2013 | 248 | 0.400 |
Why?
|
| Cell Differentiation | 22 | 2020 | 11641 | 0.390 |
Why?
|
| Swine | 21 | 2016 | 5988 | 0.390 |
Why?
|
| Arginine | 20 | 2016 | 933 | 0.380 |
Why?
|
| Gene Expression Profiling | 11 | 2017 | 9525 | 0.380 |
Why?
|
| Staining and Labeling | 2 | 2014 | 1072 | 0.370 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 16 | 2015 | 4562 | 0.370 |
Why?
|
| Green Fluorescent Proteins | 4 | 2017 | 2060 | 0.360 |
Why?
|
| Cadaver | 2 | 2013 | 1359 | 0.360 |
Why?
|
| Lasers | 3 | 2010 | 951 | 0.360 |
Why?
|
| Pancreatic Polypeptide | 7 | 2013 | 35 | 0.360 |
Why?
|
| RNA, Messenger | 28 | 2020 | 12768 | 0.350 |
Why?
|
| Pancreas, Artificial | 3 | 2012 | 54 | 0.340 |
Why?
|
| Protein Denaturation | 1 | 2010 | 240 | 0.340 |
Why?
|
| Glucokinase | 6 | 2003 | 98 | 0.340 |
Why?
|
| Male | 151 | 2024 | 363698 | 0.340 |
Why?
|
| Transcription Factors | 12 | 2015 | 12131 | 0.330 |
Why?
|
| Gene Expression | 12 | 2020 | 7584 | 0.330 |
Why?
|
| Genes, myc | 5 | 2008 | 393 | 0.320 |
Why?
|
| Antigens, Differentiation | 2 | 2004 | 919 | 0.320 |
Why?
|
| Autopsy | 1 | 2013 | 1011 | 0.310 |
Why?
|
| Adaptation, Physiological | 6 | 2002 | 1308 | 0.310 |
Why?
|
| Stem Cells | 6 | 2013 | 3540 | 0.310 |
Why?
|
| Cells, Cultured | 30 | 2019 | 18973 | 0.310 |
Why?
|
| Cell Count | 9 | 2010 | 1823 | 0.310 |
Why?
|
| Multipotent Stem Cells | 2 | 2013 | 199 | 0.310 |
Why?
|
| Rats, Inbred Strains | 27 | 1991 | 2077 | 0.310 |
Why?
|
| Proto-Oncogene Proteins c-myc | 4 | 2008 | 995 | 0.300 |
Why?
|
| Pyrrolidines | 1 | 2010 | 337 | 0.300 |
Why?
|
| Hexuronic Acids | 6 | 2013 | 144 | 0.300 |
Why?
|
| Glucuronic Acid | 6 | 2013 | 148 | 0.300 |
Why?
|
| Humans | 121 | 2024 | 765968 | 0.300 |
Why?
|
| Apoptosis | 9 | 2017 | 9514 | 0.290 |
Why?
|
| Cell Transdifferentiation | 1 | 2009 | 186 | 0.290 |
Why?
|
| Transplantation, Isogeneic | 8 | 2004 | 251 | 0.290 |
Why?
|
| NF-kappa B | 4 | 2013 | 2485 | 0.290 |
Why?
|
| Prostheses and Implants | 3 | 2020 | 1273 | 0.280 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2009 | 307 | 0.280 |
Why?
|
| Cell Culture Techniques | 11 | 2016 | 1652 | 0.270 |
Why?
|
| Cell Separation | 8 | 2010 | 1718 | 0.270 |
Why?
|
| Cell Line | 20 | 2011 | 15543 | 0.260 |
Why?
|
| Transcriptional Activation | 2 | 2003 | 1744 | 0.260 |
Why?
|
| Oxygen Consumption | 8 | 2018 | 1870 | 0.260 |
Why?
|
| Protein Precursors | 6 | 2005 | 1134 | 0.260 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 3 | 2009 | 1140 | 0.260 |
Why?
|
| DNA Primers | 9 | 2006 | 2825 | 0.260 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2010 | 318 | 0.250 |
Why?
|
| Foreign Bodies | 2 | 2023 | 402 | 0.250 |
Why?
|
| Oxygen | 7 | 2018 | 4241 | 0.240 |
Why?
|
| Nitriles | 1 | 2010 | 982 | 0.240 |
Why?
|
| Pancreas, Exocrine | 2 | 2015 | 48 | 0.240 |
Why?
|
| Biocompatible Materials | 8 | 2023 | 1682 | 0.230 |
Why?
|
| Transforming Growth Factor beta | 2 | 2004 | 1995 | 0.230 |
Why?
|
| Immunocompetence | 2 | 2016 | 138 | 0.230 |
Why?
|
| Glucose Intolerance | 2 | 2013 | 580 | 0.230 |
Why?
|
| Immunoconjugates | 2 | 2004 | 981 | 0.230 |
Why?
|
| Body Weight | 16 | 2019 | 4622 | 0.230 |
Why?
|
| Hepatocytes | 3 | 2012 | 1247 | 0.230 |
Why?
|
| Tissue Engineering | 4 | 2013 | 1855 | 0.220 |
Why?
|
| Fatty Acids, Nonesterified | 3 | 2019 | 393 | 0.220 |
Why?
|
| Hepatocyte Growth Factor | 2 | 2007 | 268 | 0.220 |
Why?
|
| Genetic Vectors | 6 | 2008 | 3404 | 0.210 |
Why?
|
| Glucagon-Like Peptide 1 | 9 | 2012 | 373 | 0.210 |
Why?
|
| Mice, Transgenic | 16 | 2015 | 9550 | 0.210 |
Why?
|
| Gastrins | 6 | 2013 | 75 | 0.210 |
Why?
|
| Immunosuppressive Agents | 7 | 2016 | 4209 | 0.210 |
Why?
|
| Neovascularization, Physiologic | 2 | 2000 | 1375 | 0.200 |
Why?
|
| Cell Survival | 8 | 2018 | 5747 | 0.200 |
Why?
|
| Oxidoreductases | 2 | 2002 | 409 | 0.200 |
Why?
|
| Kinetics | 17 | 2018 | 6274 | 0.200 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2007 | 1240 | 0.200 |
Why?
|
| Muscle Proteins | 3 | 1996 | 1158 | 0.200 |
Why?
|
| Mice, Inbred C57BL | 21 | 2019 | 22332 | 0.200 |
Why?
|
| Triiodothyronine | 2 | 2015 | 496 | 0.200 |
Why?
|
| Protein Kinase C | 4 | 2007 | 1202 | 0.200 |
Why?
|
| Macrophages, Peritoneal | 1 | 2003 | 243 | 0.200 |
Why?
|
| Inflammation | 4 | 2023 | 10850 | 0.190 |
Why?
|
| Lentivirus | 1 | 2004 | 518 | 0.190 |
Why?
|
| Hexosamines | 1 | 2001 | 40 | 0.190 |
Why?
|
| Dancing | 1 | 2022 | 105 | 0.180 |
Why?
|
| Peptide Fragments | 9 | 2005 | 5125 | 0.180 |
Why?
|
| Keratins | 3 | 2016 | 498 | 0.180 |
Why?
|
| Ubiquitin | 1 | 2006 | 839 | 0.180 |
Why?
|
| Lymph Nodes | 1 | 2012 | 3454 | 0.180 |
Why?
|
| Physical Exertion | 1 | 2004 | 665 | 0.180 |
Why?
|
| Mice, Nude | 11 | 2007 | 3618 | 0.180 |
Why?
|
| Fats | 1 | 2001 | 99 | 0.180 |
Why?
|
| DNA-Binding Proteins | 8 | 2007 | 9601 | 0.180 |
Why?
|
| Promoter Regions, Genetic | 9 | 2013 | 5786 | 0.180 |
Why?
|
| Chickens | 7 | 2010 | 842 | 0.180 |
Why?
|
| DNA | 13 | 2015 | 7202 | 0.180 |
Why?
|
| Diffusion Chambers, Culture | 2 | 1998 | 49 | 0.170 |
Why?
|
| Membranes, Artificial | 4 | 2013 | 362 | 0.170 |
Why?
|
| Bone Marrow Transplantation | 1 | 2008 | 2729 | 0.170 |
Why?
|
| Retroviridae | 1 | 2003 | 847 | 0.170 |
Why?
|
| Infusions, Intravenous | 4 | 2018 | 2229 | 0.170 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2000 | 134 | 0.170 |
Why?
|
| Disease Models, Animal | 14 | 2023 | 18293 | 0.170 |
Why?
|
| Receptors, Growth Factor | 1 | 2001 | 324 | 0.170 |
Why?
|
| Time Factors | 27 | 2016 | 40065 | 0.170 |
Why?
|
| Isoenzymes | 3 | 2012 | 1689 | 0.170 |
Why?
|
| Embryonic Stem Cells | 3 | 2016 | 1241 | 0.170 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2006 | 1314 | 0.170 |
Why?
|
| Immunoglobulin M | 1 | 2004 | 1528 | 0.170 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 9 | 2011 | 3797 | 0.160 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2000 | 323 | 0.160 |
Why?
|
| Fibrosis | 4 | 2023 | 2070 | 0.160 |
Why?
|
| Endoplasmic Reticulum | 3 | 2010 | 1132 | 0.160 |
Why?
|
| Liver | 7 | 2008 | 7562 | 0.160 |
Why?
|
| Graft Rejection | 5 | 2016 | 4499 | 0.160 |
Why?
|
| Growth Substances | 1 | 2001 | 758 | 0.160 |
Why?
|
| Glucose Transporter Type 2 | 5 | 2002 | 61 | 0.160 |
Why?
|
| Adenoviridae Infections | 1 | 1999 | 97 | 0.160 |
Why?
|
| Receptors, Glucagon | 5 | 2012 | 90 | 0.160 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2010 | 833 | 0.150 |
Why?
|
| Epithelial Cells | 3 | 2012 | 3681 | 0.150 |
Why?
|
| Epidermal Growth Factor | 3 | 2013 | 698 | 0.150 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2000 | 594 | 0.150 |
Why?
|
| Polymerase Chain Reaction | 8 | 2010 | 6069 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 2 | 2009 | 4392 | 0.140 |
Why?
|
| Genes, Reporter | 5 | 2013 | 1524 | 0.140 |
Why?
|
| Transplantation, Homologous | 8 | 2016 | 4860 | 0.140 |
Why?
|
| Remission Induction | 1 | 2023 | 2411 | 0.140 |
Why?
|
| Reference Values | 9 | 2007 | 4908 | 0.140 |
Why?
|
| Dexamethasone | 6 | 2007 | 1963 | 0.140 |
Why?
|
| Mice, Inbred NOD | 5 | 2014 | 1837 | 0.130 |
Why?
|
| Extracellular Space | 1 | 2018 | 563 | 0.130 |
Why?
|
| Hormones | 3 | 2016 | 863 | 0.130 |
Why?
|
| Base Sequence | 10 | 2014 | 12403 | 0.130 |
Why?
|
| Cell Lineage | 3 | 2014 | 2573 | 0.130 |
Why?
|
| Muscle, Skeletal | 5 | 2002 | 4958 | 0.130 |
Why?
|
| Subrenal Capsule Assay | 2 | 2009 | 27 | 0.130 |
Why?
|
| Autoimmunity | 2 | 2001 | 1354 | 0.130 |
Why?
|
| RNA | 7 | 2009 | 2717 | 0.130 |
Why?
|
| Immunoglobulin G | 2 | 2004 | 4528 | 0.120 |
Why?
|
| Triglycerides | 3 | 2000 | 2441 | 0.120 |
Why?
|
| Carbonic Anhydrases | 1 | 2016 | 107 | 0.120 |
Why?
|
| Matrix Metalloproteinase 2 | 2 | 2016 | 462 | 0.120 |
Why?
|
| Cell Proliferation | 8 | 2016 | 10429 | 0.120 |
Why?
|
| Sumoylation | 1 | 2016 | 83 | 0.120 |
Why?
|
| Immunohistochemistry | 9 | 2015 | 11022 | 0.120 |
Why?
|
| Down-Regulation | 3 | 2020 | 2927 | 0.120 |
Why?
|
| Cyclic AMP | 6 | 2012 | 1467 | 0.120 |
Why?
|
| Disease Progression | 5 | 2021 | 13632 | 0.120 |
Why?
|
| Postmortem Changes | 1 | 2014 | 119 | 0.120 |
Why?
|
| Fasting | 6 | 2001 | 1606 | 0.120 |
Why?
|
| Growth Hormone-Releasing Hormone | 2 | 2012 | 126 | 0.120 |
Why?
|
| Photosynthesis | 1 | 2014 | 69 | 0.110 |
Why?
|
| Flow Cytometry | 6 | 2019 | 5881 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factors | 3 | 2001 | 754 | 0.110 |
Why?
|
| Signal Transduction | 9 | 2017 | 23601 | 0.110 |
Why?
|
| Mice, Inbred BALB C | 5 | 2010 | 6220 | 0.110 |
Why?
|
| Culture Techniques | 4 | 2001 | 515 | 0.110 |
Why?
|
| Salicylic Acid | 1 | 2013 | 60 | 0.110 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2001 | 1624 | 0.110 |
Why?
|
| Brain Death | 1 | 2017 | 360 | 0.110 |
Why?
|
| Perfusion | 12 | 1992 | 1407 | 0.110 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2014 | 213 | 0.110 |
Why?
|
| Phlorhizin | 3 | 2001 | 37 | 0.110 |
Why?
|
| Repressor Proteins | 2 | 2005 | 2968 | 0.110 |
Why?
|
| Epinephrine | 10 | 1987 | 783 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2017 | 3607 | 0.100 |
Why?
|
| Organ Culture Techniques | 3 | 2005 | 788 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-maf | 1 | 2013 | 69 | 0.100 |
Why?
|
| Cyclic AMP Response Element Modulator | 3 | 2008 | 88 | 0.100 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2009 | 691 | 0.100 |
Why?
|
| Congresses as Topic | 2 | 2016 | 811 | 0.100 |
Why?
|
| Apolipoproteins E | 1 | 2018 | 1458 | 0.100 |
Why?
|
| Phenotype | 4 | 2018 | 16721 | 0.100 |
Why?
|
| Diabetic Nephropathies | 3 | 2008 | 969 | 0.100 |
Why?
|
| Ligation | 1 | 2013 | 444 | 0.100 |
Why?
|
| Cell Growth Processes | 1 | 2013 | 381 | 0.100 |
Why?
|
| Tissue Survival | 1 | 2012 | 121 | 0.100 |
Why?
|
| Malate Dehydrogenase | 2 | 2011 | 40 | 0.100 |
Why?
|
| Expert Testimony | 1 | 2014 | 266 | 0.100 |
Why?
|
| Preventive Medicine | 1 | 2014 | 246 | 0.100 |
Why?
|
| Adenosine Kinase | 1 | 2012 | 13 | 0.100 |
Why?
|
| Regenerative Medicine | 1 | 2016 | 303 | 0.100 |
Why?
|
| Boronic Acids | 1 | 2016 | 916 | 0.100 |
Why?
|
| Cell Hypoxia | 2 | 2012 | 647 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 18071 | 0.100 |
Why?
|
| Athletic Injuries | 1 | 2022 | 1240 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 6 | 2016 | 2476 | 0.100 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2009 | 1167 | 0.100 |
Why?
|
| Fatty Acids | 3 | 1997 | 1806 | 0.100 |
Why?
|
| Proteins | 4 | 2002 | 5995 | 0.100 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2001 | 3672 | 0.090 |
Why?
|
| Female | 39 | 2022 | 396112 | 0.090 |
Why?
|
| Epigenesis, Genetic | 2 | 2016 | 3819 | 0.090 |
Why?
|
| Receptor, IGF Type 1 | 2 | 2017 | 385 | 0.090 |
Why?
|
| Vimentin | 2 | 2004 | 258 | 0.090 |
Why?
|
| Immune Sera | 4 | 1981 | 601 | 0.090 |
Why?
|
| Radioimmunoassay | 9 | 2010 | 860 | 0.090 |
Why?
|
| Swine, Miniature | 1 | 2013 | 971 | 0.090 |
Why?
|
| Cytokines | 2 | 2023 | 7421 | 0.090 |
Why?
|
| Superoxide Dismutase | 1 | 2013 | 593 | 0.090 |
Why?
|
| Diffusion | 4 | 2013 | 808 | 0.090 |
Why?
|
| Lipids | 3 | 2000 | 3315 | 0.090 |
Why?
|
| Prediabetic State | 1 | 2016 | 548 | 0.090 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2017 | 1140 | 0.090 |
Why?
|
| Organ Size | 6 | 2010 | 2260 | 0.090 |
Why?
|
| Peritoneal Cavity | 2 | 2004 | 133 | 0.090 |
Why?
|
| Matrix Metalloproteinase 7 | 1 | 2010 | 60 | 0.090 |
Why?
|
| Necrosis | 2 | 2010 | 1617 | 0.090 |
Why?
|
| Palmitates | 1 | 2010 | 68 | 0.080 |
Why?
|
| Biomimetic Materials | 1 | 2011 | 170 | 0.080 |
Why?
|
| Insulin-Like Growth Factor I | 3 | 2008 | 1936 | 0.080 |
Why?
|
| Models, Animal | 2 | 2008 | 2120 | 0.080 |
Why?
|
| Cattle | 5 | 2001 | 3801 | 0.080 |
Why?
|
| Temperature | 2 | 2014 | 2226 | 0.080 |
Why?
|
| Plaque, Amyloid | 1 | 2014 | 772 | 0.080 |
Why?
|
| Glyburide | 2 | 1988 | 117 | 0.080 |
Why?
|
| Cloning, Molecular | 4 | 2014 | 4165 | 0.080 |
Why?
|
| Polyglycolic Acid | 3 | 2013 | 406 | 0.080 |
Why?
|
| Transplantation Immunology | 1 | 2011 | 541 | 0.080 |
Why?
|
| Herpes Simplex Virus Protein Vmw65 | 1 | 2009 | 27 | 0.080 |
Why?
|
| Collagenases | 1 | 2009 | 221 | 0.080 |
Why?
|
| Clinical Trials as Topic | 4 | 2018 | 8041 | 0.080 |
Why?
|
| Cell Membrane | 4 | 2015 | 3634 | 0.080 |
Why?
|
| RNA, Small Interfering | 6 | 2008 | 3421 | 0.080 |
Why?
|
| Kidney | 9 | 2009 | 7066 | 0.080 |
Why?
|
| Transplantation, Autologous | 2 | 2015 | 2120 | 0.080 |
Why?
|
| Mesangial Cells | 1 | 2008 | 22 | 0.080 |
Why?
|
| Biological Assay | 3 | 2011 | 627 | 0.080 |
Why?
|
| Gene Deletion | 1 | 2016 | 2666 | 0.080 |
Why?
|
| Duodenum | 3 | 1980 | 495 | 0.070 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 5 | 1986 | 99 | 0.070 |
Why?
|
| Tissue Preservation | 1 | 2009 | 169 | 0.070 |
Why?
|
| Adult | 21 | 2022 | 223044 | 0.070 |
Why?
|
| Transcription, Genetic | 5 | 2005 | 7599 | 0.070 |
Why?
|
| Cell Nucleus | 3 | 2013 | 2867 | 0.070 |
Why?
|
| Mice, SCID | 2 | 2010 | 2630 | 0.070 |
Why?
|
| Polymers | 2 | 2016 | 1621 | 0.070 |
Why?
|
| STAT5 Transcription Factor | 1 | 2008 | 269 | 0.070 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2008 | 178 | 0.070 |
Why?
|
| Autocrine Communication | 1 | 2008 | 167 | 0.070 |
Why?
|
| Microarray Analysis | 1 | 2010 | 752 | 0.070 |
Why?
|
| Chemokine CCL2 | 1 | 2010 | 602 | 0.070 |
Why?
|
| Eating | 5 | 2001 | 1540 | 0.070 |
Why?
|
| Glucose Transporter Type 4 | 3 | 1996 | 240 | 0.070 |
Why?
|
| Stem Cell Transplantation | 1 | 2016 | 1602 | 0.070 |
Why?
|
| Transfection | 6 | 2005 | 5743 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2010 | 3737 | 0.070 |
Why?
|
| Receptors, Gastrointestinal Hormone | 1 | 2007 | 45 | 0.070 |
Why?
|
| Analysis of Variance | 3 | 2010 | 6203 | 0.070 |
Why?
|
| Biomedical Research | 2 | 2016 | 3458 | 0.070 |
Why?
|
| Antigens, CD | 3 | 2004 | 4025 | 0.070 |
Why?
|
| Fetal Tissue Transplantation | 2 | 1998 | 139 | 0.070 |
Why?
|
| Recombinant Proteins | 5 | 2013 | 6493 | 0.070 |
Why?
|
| Kidney Glomerulus | 2 | 2008 | 568 | 0.070 |
Why?
|
| Myocardium | 4 | 2007 | 4760 | 0.070 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2007 | 145 | 0.070 |
Why?
|
| Glucagon-Like Peptides | 4 | 1995 | 157 | 0.070 |
Why?
|
| Angiotensins | 1 | 2007 | 139 | 0.070 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 1624 | 0.070 |
Why?
|
| Paired Box Transcription Factors | 1 | 2007 | 204 | 0.070 |
Why?
|
| alpha-Fetoproteins | 1 | 2007 | 226 | 0.070 |
Why?
|
| Hepatocyte Nuclear Factor 1 | 1 | 2005 | 27 | 0.060 |
Why?
|
| Enzyme Activation | 2 | 2002 | 3586 | 0.060 |
Why?
|
| Tissue Scaffolds | 1 | 2012 | 934 | 0.060 |
Why?
|
| Ischemia | 1 | 2014 | 1909 | 0.060 |
Why?
|
| Polyvinyl Alcohol | 2 | 1996 | 74 | 0.060 |
Why?
|
| SNARE Proteins | 1 | 2005 | 80 | 0.060 |
Why?
|
| Rodentia | 2 | 2019 | 261 | 0.060 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1986 | 304 | 0.060 |
Why?
|
| Fishes | 6 | 1983 | 606 | 0.060 |
Why?
|
| Culture Media | 2 | 2001 | 890 | 0.060 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2001 | 852 | 0.060 |
Why?
|
| Cyclin A | 1 | 2005 | 59 | 0.060 |
Why?
|
| Barium Compounds | 1 | 2005 | 20 | 0.060 |
Why?
|
| Extracellular Matrix | 1 | 1993 | 1727 | 0.060 |
Why?
|
| Cell Communication | 2 | 1990 | 1660 | 0.060 |
Why?
|
| Models, Biological | 8 | 2010 | 9443 | 0.060 |
Why?
|
| Glucose Clamp Technique | 2 | 2007 | 262 | 0.060 |
Why?
|
| Neurons | 1 | 2004 | 9525 | 0.060 |
Why?
|
| Tissue Culture Techniques | 2 | 2018 | 286 | 0.060 |
Why?
|
| Norepinephrine | 4 | 2014 | 900 | 0.060 |
Why?
|
| High-Throughput Screening Assays | 1 | 2010 | 938 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2001 | 3513 | 0.060 |
Why?
|
| DNA Methylation | 2 | 2016 | 4424 | 0.060 |
Why?
|
| Chronic Disease | 5 | 2002 | 9347 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 10 | 2005 | 10729 | 0.060 |
Why?
|
| Blotting, Western | 5 | 2016 | 5020 | 0.060 |
Why?
|
| CD40 Ligand | 1 | 2006 | 528 | 0.060 |
Why?
|
| Liver Diseases | 1 | 2012 | 1303 | 0.060 |
Why?
|
| Materials Testing | 3 | 2012 | 868 | 0.060 |
Why?
|
| Young Adult | 4 | 2022 | 59889 | 0.050 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2012 | 618 | 0.050 |
Why?
|
| Serum Albumin | 1 | 2007 | 675 | 0.050 |
Why?
|
| Microscopy, Electron | 3 | 2010 | 2548 | 0.050 |
Why?
|
| Mitosis | 3 | 2002 | 1173 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2013 | 1808 | 0.050 |
Why?
|
| Cysteine Endopeptidases | 1 | 2006 | 542 | 0.050 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2007 | 426 | 0.050 |
Why?
|
| Clodronic Acid | 1 | 2003 | 60 | 0.050 |
Why?
|
| Middle Aged | 17 | 2017 | 223009 | 0.050 |
Why?
|
| Actins | 1 | 2010 | 2056 | 0.050 |
Why?
|
| Primates | 2 | 2016 | 518 | 0.050 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2006 | 456 | 0.050 |
Why?
|
| Treatment Outcome | 7 | 2016 | 65188 | 0.050 |
Why?
|
| Receptor, Insulin | 3 | 2005 | 837 | 0.050 |
Why?
|
| Spleen | 2 | 2001 | 2296 | 0.050 |
Why?
|
| Gels | 1 | 2024 | 419 | 0.050 |
Why?
|
| Immune System | 1 | 2008 | 799 | 0.050 |
Why?
|
| Interleukin-1beta | 1 | 2008 | 1028 | 0.050 |
Why?
|
| Cell Cycle | 1 | 2010 | 2920 | 0.050 |
Why?
|
| Laminin | 2 | 2005 | 404 | 0.050 |
Why?
|
| Fibroblasts | 2 | 2012 | 4159 | 0.050 |
Why?
|
| Electrophoresis | 1 | 2002 | 226 | 0.050 |
Why?
|
| Chlorides | 1 | 2005 | 666 | 0.050 |
Why?
|
| Age of Onset | 1 | 2009 | 3344 | 0.050 |
Why?
|
| Insulinoma | 3 | 2005 | 121 | 0.050 |
Why?
|
| Embryo, Nonmammalian | 1 | 2005 | 907 | 0.050 |
Why?
|
| Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing) | 1 | 2001 | 11 | 0.050 |
Why?
|
| Immunologic Techniques | 2 | 1996 | 212 | 0.050 |
Why?
|
| Autophagy | 1 | 2009 | 1351 | 0.050 |
Why?
|
| Pluripotent Stem Cells | 1 | 2008 | 807 | 0.050 |
Why?
|
| Genes, bcl-2 | 1 | 2001 | 119 | 0.050 |
Why?
|
| Nonmuscle Myosin Type IIB | 1 | 2001 | 21 | 0.050 |
Why?
|
| Acyl-CoA Oxidase | 1 | 2001 | 7 | 0.050 |
Why?
|
| Glycogen | 1 | 2002 | 251 | 0.050 |
Why?
|
| Phosphoproteins | 3 | 2005 | 2446 | 0.050 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2001 | 81 | 0.040 |
Why?
|
| Polylysine | 1 | 2001 | 130 | 0.040 |
Why?
|
| Transcription Factor RelA | 1 | 2002 | 252 | 0.040 |
Why?
|
| Adolescent | 5 | 2018 | 88835 | 0.040 |
Why?
|
| Adenosine Triphosphate | 3 | 2003 | 1999 | 0.040 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2000 | 74 | 0.040 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2002 | 440 | 0.040 |
Why?
|
| APUD Cells | 1 | 1980 | 5 | 0.040 |
Why?
|
| Collagen Type I | 1 | 2024 | 615 | 0.040 |
Why?
|
| Digestive System | 1 | 1981 | 244 | 0.040 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2001 | 190 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2002 | 512 | 0.040 |
Why?
|
| Nephrectomy | 1 | 2005 | 927 | 0.040 |
Why?
|
| Physical Conditioning, Animal | 1 | 2004 | 366 | 0.040 |
Why?
|
| Autonomic Nervous System | 2 | 1986 | 706 | 0.040 |
Why?
|
| Dogs | 9 | 1981 | 3822 | 0.040 |
Why?
|
| Antibody Formation | 1 | 2004 | 1391 | 0.040 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2001 | 298 | 0.040 |
Why?
|
| Amyloid | 2 | 1996 | 853 | 0.040 |
Why?
|
| Keratin-7 | 1 | 1999 | 55 | 0.040 |
Why?
|
| Microscopy, Confocal | 2 | 2016 | 1966 | 0.040 |
Why?
|
| Ganglia | 1 | 1980 | 86 | 0.040 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2007 | 1657 | 0.040 |
Why?
|
| Niacinamide | 2 | 2001 | 419 | 0.040 |
Why?
|
| Cushing Syndrome | 1 | 1981 | 241 | 0.040 |
Why?
|
| Pancreatic Hormones | 1 | 1999 | 12 | 0.040 |
Why?
|
| Adipose Tissue | 3 | 1997 | 3312 | 0.040 |
Why?
|
| Myosin Heavy Chains | 1 | 2001 | 402 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2005 | 1673 | 0.040 |
Why?
|
| Electrochemistry | 1 | 1999 | 142 | 0.040 |
Why?
|
| Lac Operon | 1 | 1999 | 238 | 0.040 |
Why?
|
| Liposomes | 1 | 2003 | 788 | 0.040 |
Why?
|
| HeLa Cells | 2 | 2003 | 3067 | 0.040 |
Why?
|
| Acetylcholine | 2 | 1980 | 626 | 0.040 |
Why?
|
| Dietary Fats | 1 | 2007 | 2002 | 0.040 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 1979 | 146 | 0.040 |
Why?
|
| Nitric Oxide Synthase | 1 | 2002 | 911 | 0.040 |
Why?
|
| Receptors, Adrenergic | 1 | 1979 | 155 | 0.040 |
Why?
|
| Pancreatitis | 2 | 2015 | 1087 | 0.040 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2018 | 111 | 0.040 |
Why?
|
| Drug Compounding | 1 | 2019 | 235 | 0.040 |
Why?
|
| Aged | 8 | 2017 | 171117 | 0.040 |
Why?
|
| beta-Galactosidase | 1 | 1999 | 572 | 0.040 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1979 | 242 | 0.040 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2001 | 314 | 0.040 |
Why?
|
| Glycosylation | 1 | 2001 | 1100 | 0.040 |
Why?
|
| Immunoblotting | 3 | 2005 | 1644 | 0.040 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2020 | 314 | 0.040 |
Why?
|
| Injections, Intramuscular | 1 | 1999 | 552 | 0.040 |
Why?
|
| Permeability | 1 | 2020 | 726 | 0.040 |
Why?
|
| Nuclear Proteins | 3 | 2007 | 5783 | 0.040 |
Why?
|
| STAT Transcription Factors | 1 | 2018 | 189 | 0.040 |
Why?
|
| Gene Transfer Techniques | 1 | 2003 | 1216 | 0.040 |
Why?
|
| Acyl Coenzyme A | 1 | 1997 | 57 | 0.040 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2001 | 660 | 0.040 |
Why?
|
| Genes | 4 | 1989 | 1825 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2001 | 561 | 0.040 |
Why?
|
| Brain Chemistry | 1 | 1981 | 952 | 0.040 |
Why?
|
| Hemolytic Plaque Technique | 1 | 2017 | 59 | 0.040 |
Why?
|
| Adenoma, Islet Cell | 3 | 1983 | 72 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2001 | 1336 | 0.040 |
Why?
|
| Cell Line, Transformed | 1 | 1998 | 858 | 0.040 |
Why?
|
| Janus Kinases | 1 | 2018 | 253 | 0.030 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 1999 | 287 | 0.030 |
Why?
|
| Liver Transplantation | 1 | 2009 | 2412 | 0.030 |
Why?
|
| Aging | 3 | 2017 | 8731 | 0.030 |
Why?
|
| Nerve Growth Factors | 1 | 1980 | 565 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2010 | 3111 | 0.030 |
Why?
|
| Cadherins | 1 | 2001 | 900 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 2009 | 4778 | 0.030 |
Why?
|
| Glutamate Dehydrogenase | 1 | 2016 | 50 | 0.030 |
Why?
|
| Insulin Receptor Substrate Proteins | 3 | 2005 | 558 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2000 | 561 | 0.030 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2016 | 110 | 0.030 |
Why?
|
| Interleukin-8 | 2 | 2010 | 700 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2001 | 1816 | 0.030 |
Why?
|
| Rhodamines | 1 | 2016 | 178 | 0.030 |
Why?
|
| Receptors, LDL | 1 | 2018 | 491 | 0.030 |
Why?
|
| Polymerization | 1 | 2016 | 156 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2012 | 7851 | 0.030 |
Why?
|
| Erythropoietin | 1 | 2020 | 716 | 0.030 |
Why?
|
| Delayed-Action Preparations | 1 | 2019 | 967 | 0.030 |
Why?
|
| Proteoglycans | 1 | 1998 | 793 | 0.030 |
Why?
|
| Cholesterol | 2 | 2005 | 2898 | 0.030 |
Why?
|
| Reproducibility of Results | 4 | 2016 | 20124 | 0.030 |
Why?
|
| Calcium Channels | 1 | 1999 | 622 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 2003 | 6113 | 0.030 |
Why?
|
| Hypertrophy | 2 | 2005 | 559 | 0.030 |
Why?
|
| Surface Properties | 2 | 2010 | 1151 | 0.030 |
Why?
|
| Rheology | 1 | 2016 | 348 | 0.030 |
Why?
|
| Hypoglycemic Agents | 2 | 2016 | 3110 | 0.030 |
Why?
|
| Laboratories | 1 | 1999 | 462 | 0.030 |
Why?
|
| Microscopy | 2 | 2010 | 901 | 0.030 |
Why?
|
| Theophylline | 3 | 2001 | 132 | 0.030 |
Why?
|
| Nucleosides | 1 | 1975 | 130 | 0.030 |
Why?
|
| Liver Regeneration | 1 | 1976 | 214 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2005 | 3690 | 0.030 |
Why?
|
| Densitometry | 1 | 1995 | 150 | 0.030 |
Why?
|
| Synechococcus | 1 | 2014 | 30 | 0.030 |
Why?
|
| Epididymis | 1 | 1996 | 226 | 0.030 |
Why?
|
| Tyrosine | 1 | 1999 | 1428 | 0.030 |
Why?
|
| Mice, Knockout | 3 | 2016 | 14448 | 0.030 |
Why?
|
| Fetal Blood | 1 | 2001 | 1369 | 0.030 |
Why?
|
| Papio | 2 | 2009 | 671 | 0.030 |
Why?
|
| Microcirculation | 1 | 1999 | 1280 | 0.030 |
Why?
|
| RNA, Catalytic | 1 | 1994 | 52 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2009 | 414 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2000 | 2601 | 0.030 |
Why?
|
| Structure-Activity Relationship | 2 | 1997 | 3051 | 0.030 |
Why?
|
| Ligases | 2 | 1973 | 330 | 0.030 |
Why?
|
| Hypocalcemia | 1 | 1975 | 205 | 0.030 |
Why?
|
| Aniline Compounds | 1 | 2019 | 1075 | 0.030 |
Why?
|
| Langerhans Cells | 1 | 1994 | 170 | 0.030 |
Why?
|
| Paresthesia | 1 | 2014 | 160 | 0.030 |
Why?
|
| Connective Tissue | 1 | 1995 | 425 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1995 | 1600 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2001 | 2878 | 0.030 |
Why?
|
| Injections | 1 | 2016 | 840 | 0.030 |
Why?
|
| Immunoprecipitation | 2 | 2005 | 870 | 0.030 |
Why?
|
| Osmolar Concentration | 2 | 1999 | 655 | 0.030 |
Why?
|
| Protein Transport | 2 | 2013 | 1939 | 0.030 |
Why?
|
| Nucleotides | 1 | 1975 | 451 | 0.030 |
Why?
|
| Biomass | 1 | 2013 | 136 | 0.030 |
Why?
|
| Genetic Engineering | 1 | 1998 | 933 | 0.030 |
Why?
|
| Morpholines | 1 | 2016 | 577 | 0.030 |
Why?
|
| Macrophages | 2 | 2019 | 5772 | 0.030 |
Why?
|
| Reference Standards | 1 | 2016 | 1013 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2016 | 791 | 0.030 |
Why?
|
| Sulfonamides | 2 | 2019 | 1984 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2002 | 2132 | 0.020 |
Why?
|
| Implants, Experimental | 1 | 2012 | 98 | 0.020 |
Why?
|
| Drug Combinations | 1 | 1998 | 2077 | 0.020 |
Why?
|
| Isoproterenol | 3 | 1981 | 398 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2005 | 857 | 0.020 |
Why?
|
| Aplysia | 2 | 1983 | 40 | 0.020 |
Why?
|
| Oviposition | 2 | 1983 | 22 | 0.020 |
Why?
|
| Cathepsins | 1 | 2013 | 242 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2003 | 2892 | 0.020 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2013 | 202 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2016 | 990 | 0.020 |
Why?
|
| Age Factors | 1 | 2009 | 18380 | 0.020 |
Why?
|
| Subcutaneous Tissue | 1 | 2012 | 130 | 0.020 |
Why?
|
| Porosity | 1 | 2012 | 347 | 0.020 |
Why?
|
| Equipment Design | 1 | 2020 | 3481 | 0.020 |
Why?
|
| Mouth Mucosa | 1 | 2014 | 432 | 0.020 |
Why?
|
| Receptors, Cell Surface | 2 | 2000 | 2817 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2016 | 2477 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 59489 | 0.020 |
Why?
|
| Insurance Carriers | 1 | 1993 | 159 | 0.020 |
Why?
|
| Microscopy, Immunoelectron | 2 | 2005 | 315 | 0.020 |
Why?
|
| Biological Transport | 1 | 1996 | 2081 | 0.020 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2012 | 412 | 0.020 |
Why?
|
| Phylogeny | 1 | 1979 | 2832 | 0.020 |
Why?
|
| Molecular Weight | 3 | 1981 | 2163 | 0.020 |
Why?
|
| Nausea | 1 | 2014 | 680 | 0.020 |
Why?
|
| Octoxynol | 1 | 2011 | 76 | 0.020 |
Why?
|
| Glycerolphosphate Dehydrogenase | 1 | 2011 | 40 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2015 | 1638 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2001 | 2900 | 0.020 |
Why?
|
| Erythrocytes | 2 | 1973 | 2395 | 0.020 |
Why?
|
| Iodide Peroxidase | 1 | 2013 | 297 | 0.020 |
Why?
|
| Rats, Zucker | 2 | 2003 | 129 | 0.020 |
Why?
|
| Diffusion of Innovation | 1 | 2016 | 721 | 0.020 |
Why?
|
| Dithizone | 1 | 2010 | 2 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 1994 | 1701 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 5 | 1983 | 5444 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 2014 | 561 | 0.020 |
Why?
|
| Transplantation Tolerance | 1 | 2016 | 640 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2020 | 4260 | 0.020 |
Why?
|
| Social Responsibility | 1 | 1993 | 382 | 0.020 |
Why?
|
| Diabetic Foot | 1 | 1994 | 384 | 0.020 |
Why?
|
| Endothelium, Corneal | 1 | 1993 | 212 | 0.020 |
Why?
|
| Politics | 1 | 1997 | 822 | 0.020 |
Why?
|
| Expressed Sequence Tags | 1 | 2011 | 251 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 1991 | 1526 | 0.020 |
Why?
|
| Triazoles | 1 | 2016 | 897 | 0.020 |
Why?
|
| Collagen | 1 | 1998 | 2618 | 0.020 |
Why?
|
| Edetic Acid | 1 | 2011 | 274 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 2 | 2009 | 3750 | 0.020 |
Why?
|
| Static Electricity | 1 | 2011 | 259 | 0.020 |
Why?
|
| Propranolol | 3 | 1981 | 492 | 0.020 |
Why?
|
| Plasma | 1 | 1973 | 579 | 0.020 |
Why?
|
| Models, Theoretical | 2 | 2005 | 3564 | 0.020 |
Why?
|
| Chemokine CXCL1 | 1 | 2010 | 102 | 0.020 |
Why?
|
| Drug Synergism | 3 | 1989 | 1749 | 0.020 |
Why?
|
| Child | 1 | 2018 | 80564 | 0.020 |
Why?
|
| Stimulation, Chemical | 4 | 1980 | 303 | 0.020 |
Why?
|
| Genes, ras | 1 | 1992 | 658 | 0.020 |
Why?
|
| Molecular Sequence Data | 5 | 2005 | 17594 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2016 | 1192 | 0.020 |
Why?
|
| Cell Movement | 1 | 2001 | 5194 | 0.020 |
Why?
|
| Aspartate Aminotransferases | 1 | 2011 | 415 | 0.020 |
Why?
|
| Interleukin-6 | 2 | 2010 | 3222 | 0.020 |
Why?
|
| Quality Control | 1 | 2012 | 837 | 0.020 |
Why?
|
| Infusions, Parenteral | 1 | 1989 | 395 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 2 | 2005 | 1306 | 0.020 |
Why?
|
| T-Lymphocytes | 2 | 2008 | 10261 | 0.020 |
Why?
|
| Glycolysis | 1 | 2012 | 838 | 0.020 |
Why?
|
| Acute Disease | 2 | 1996 | 7232 | 0.020 |
Why?
|
| Proteome | 1 | 2018 | 1899 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2016 | 1930 | 0.020 |
Why?
|
| Random Allocation | 1 | 2013 | 2395 | 0.020 |
Why?
|
| Erythrocyte Aging | 1 | 1968 | 51 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2005 | 2880 | 0.020 |
Why?
|
| Prosthesis Implantation | 1 | 2012 | 595 | 0.020 |
Why?
|
| Ferrosoferric Oxide | 1 | 2009 | 349 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2013 | 1718 | 0.020 |
Why?
|
| Microchip Analytical Procedures | 1 | 2007 | 28 | 0.020 |
Why?
|
| Immunomodulation | 1 | 2012 | 547 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2013 | 1137 | 0.020 |
Why?
|
| Chromatography, Gel | 2 | 1981 | 629 | 0.020 |
Why?
|
| Partial Pressure | 1 | 2007 | 245 | 0.020 |
Why?
|
| Transcription Factor CHOP | 1 | 2007 | 69 | 0.020 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2008 | 220 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2010 | 1745 | 0.020 |
Why?
|
| Small Molecule Libraries | 1 | 2013 | 741 | 0.020 |
Why?
|
| Magnetite Nanoparticles | 1 | 2009 | 309 | 0.020 |
Why?
|
| Oxides | 1 | 2009 | 402 | 0.020 |
Why?
|
| ROC Curve | 1 | 2015 | 3620 | 0.020 |
Why?
|
| NADP | 1 | 2008 | 229 | 0.020 |
Why?
|
| Chimera | 1 | 2008 | 455 | 0.020 |
Why?
|
| Dextrans | 1 | 2009 | 571 | 0.020 |
Why?
|
| Immune Tolerance | 1 | 2016 | 2324 | 0.020 |
Why?
|
| Phosphorylation | 3 | 2005 | 8278 | 0.020 |
Why?
|
| CA-19-9 Antigen | 1 | 2007 | 109 | 0.020 |
Why?
|
| Drinking | 1 | 1988 | 196 | 0.020 |
Why?
|
| Chimerism | 1 | 2008 | 154 | 0.020 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2007 | 61 | 0.020 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2008 | 282 | 0.020 |
Why?
|
| Risk Factors | 3 | 2022 | 74840 | 0.020 |
Why?
|
| Forecasting | 1 | 2016 | 2936 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 2 | 1996 | 1957 | 0.020 |
Why?
|
| Drug Implants | 1 | 2007 | 230 | 0.020 |
Why?
|
| Secretory Rate | 1 | 1986 | 82 | 0.020 |
Why?
|
| Virus Integration | 1 | 2008 | 304 | 0.020 |
Why?
|
| Captopril | 1 | 2007 | 261 | 0.020 |
Why?
|
| Atropine | 3 | 1981 | 242 | 0.020 |
Why?
|
| Rubber | 1 | 2005 | 32 | 0.020 |
Why?
|
| Obesity | 4 | 2014 | 13076 | 0.020 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2008 | 506 | 0.020 |
Why?
|
| Hyperplasia | 1 | 1989 | 1144 | 0.020 |
Why?
|
| Teratoma | 1 | 2008 | 401 | 0.020 |
Why?
|
| Fluorocarbons | 1 | 2011 | 497 | 0.020 |
Why?
|
| Intercellular Junctions | 1 | 1986 | 198 | 0.020 |
Why?
|
| Islet Amyloid Polypeptide | 2 | 1996 | 41 | 0.020 |
Why?
|
| Growth Hormone | 2 | 2005 | 566 | 0.020 |
Why?
|
| Models, Genetic | 2 | 2005 | 3449 | 0.020 |
Why?
|
| Diabetic Retinopathy | 1 | 1994 | 1299 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2013 | 2140 | 0.020 |
Why?
|
| Transgenes | 1 | 2008 | 1015 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 1989 | 1385 | 0.010 |
Why?
|
| Collagen Type IV | 1 | 2005 | 124 | 0.010 |
Why?
|
| Dactinomycin | 1 | 2005 | 304 | 0.010 |
Why?
|
| Proteomics | 1 | 2018 | 3910 | 0.010 |
Why?
|
| Administration, Oral | 1 | 1993 | 4015 | 0.010 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1993 | 2203 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2005 | 463 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1986 | 696 | 0.010 |
Why?
|
| Silicones | 1 | 2005 | 228 | 0.010 |
Why?
|
| Tolbutamide | 2 | 1981 | 23 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 1996 | 2226 | 0.010 |
Why?
|
| Exocytosis | 1 | 2005 | 323 | 0.010 |
Why?
|
| Rabbits | 4 | 1996 | 4734 | 0.010 |
Why?
|
| Charcoal | 2 | 1975 | 68 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2016 | 3956 | 0.010 |
Why?
|
| Incidence | 1 | 2022 | 21480 | 0.010 |
Why?
|
| Invertebrate Hormones | 1 | 1983 | 24 | 0.010 |
Why?
|
| Castration | 1 | 1984 | 149 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2005 | 1546 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 2005 | 1300 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 2 | 2005 | 2627 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2010 | 3089 | 0.010 |
Why?
|
| Macaca fascicularis | 1 | 2006 | 907 | 0.010 |
Why?
|
| Rats, Mutant Strains | 1 | 2003 | 59 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2005 | 562 | 0.010 |
Why?
|
| Heat-Shock Proteins | 1 | 2007 | 791 | 0.010 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2003 | 70 | 0.010 |
Why?
|
| Models, Chemical | 1 | 2005 | 608 | 0.010 |
Why?
|
| Dopa Decarboxylase | 1 | 1983 | 14 | 0.010 |
Why?
|
| Aromatic-L-Amino-Acid Decarboxylases | 1 | 1983 | 27 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 1724 | 0.010 |
Why?
|
| Intestinal Mucosa | 3 | 1984 | 3046 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3807 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2012 | 2056 | 0.010 |
Why?
|
| Mutation | 3 | 2012 | 30198 | 0.010 |
Why?
|
| Molecular Chaperones | 1 | 2007 | 762 | 0.010 |
Why?
|
| Albumins | 1 | 2005 | 577 | 0.010 |
Why?
|
| Skin | 1 | 1996 | 4489 | 0.010 |
Why?
|
| Cell Line, Tumor | 2 | 2010 | 17075 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2005 | 1984 | 0.010 |
Why?
|
| Glucose-6-Phosphate | 1 | 2002 | 29 | 0.010 |
Why?
|
| Glycogen Synthase Kinases | 1 | 2001 | 40 | 0.010 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 2001 | 46 | 0.010 |
Why?
|
| Glycogen Synthase | 1 | 2002 | 62 | 0.010 |
Why?
|
| Photons | 1 | 2005 | 572 | 0.010 |
Why?
|
| Bombesin | 1 | 1981 | 35 | 0.010 |
Why?
|
| Gastric Juice | 1 | 1981 | 59 | 0.010 |
Why?
|
| ACTH Syndrome, Ectopic | 1 | 1981 | 30 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2003 | 1081 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2005 | 2266 | 0.010 |
Why?
|
| Phosphoserine | 1 | 2001 | 203 | 0.010 |
Why?
|
| Autonomic Fibers, Preganglionic | 1 | 1980 | 7 | 0.010 |
Why?
|
| TATA-Box Binding Protein | 1 | 2001 | 99 | 0.010 |
Why?
|
| Phosphotyrosine | 1 | 2001 | 459 | 0.010 |
Why?
|
| Methacholine Compounds | 1 | 1980 | 35 | 0.010 |
Why?
|
| Clonidine | 1 | 2001 | 165 | 0.010 |
Why?
|
| Iron | 1 | 2009 | 1816 | 0.010 |
Why?
|
| Coenzyme A | 2 | 1973 | 39 | 0.010 |
Why?
|
| History, 20th Century | 1 | 2008 | 2761 | 0.010 |
Why?
|
| Calcium | 2 | 2005 | 5767 | 0.010 |
Why?
|
| Prostaglandins E | 1 | 1980 | 166 | 0.010 |
Why?
|
| Azathioprine | 1 | 2002 | 350 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2001 | 490 | 0.010 |
Why?
|
| Receptors, Muscarinic | 1 | 1980 | 156 | 0.010 |
Why?
|
| Gastrointestinal Hormones | 1 | 1980 | 101 | 0.010 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 1980 | 179 | 0.010 |
Why?
|
| Pyloric Antrum | 1 | 1980 | 66 | 0.010 |
Why?
|
| Splenectomy | 1 | 2002 | 390 | 0.010 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2007 | 1514 | 0.010 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2012 | 1883 | 0.010 |
Why?
|
| Antilymphocyte Serum | 1 | 2002 | 493 | 0.010 |
Why?
|
| Para-Aortic Bodies | 1 | 1979 | 3 | 0.010 |
Why?
|
| Chromaffin System | 1 | 1979 | 15 | 0.010 |
Why?
|
| Antigen-Antibody Complex | 1 | 1981 | 508 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2022 | 54802 | 0.010 |
Why?
|
| Gonads | 1 | 1980 | 109 | 0.010 |
Why?
|
| Receptors, Cholinergic | 1 | 1980 | 243 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 1984 | 931 | 0.010 |
Why?
|
| Depression, Chemical | 2 | 1980 | 186 | 0.010 |
Why?
|
| Deoxyglucose | 2 | 1984 | 321 | 0.010 |
Why?
|
| Reticulocytes | 2 | 1973 | 287 | 0.010 |
Why?
|
| Reptiles | 1 | 1979 | 9 | 0.010 |
Why?
|
| Keto Acids | 1 | 1999 | 32 | 0.010 |
Why?
|
| Amphibians | 1 | 1979 | 29 | 0.010 |
Why?
|
| Stomach | 1 | 1984 | 699 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2008 | 4137 | 0.010 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 1999 | 89 | 0.010 |
Why?
|
| Cyclosporine | 1 | 2002 | 778 | 0.010 |
Why?
|
| Postprandial Period | 1 | 2001 | 319 | 0.010 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 1999 | 187 | 0.010 |
Why?
|
| Protein Binding | 2 | 2005 | 9296 | 0.010 |
Why?
|
| Exons | 1 | 2005 | 2391 | 0.010 |
Why?
|
| Amino Acids | 2 | 1983 | 1709 | 0.010 |
Why?
|
| Sheep | 1 | 1981 | 1440 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1999 | 339 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2001 | 634 | 0.010 |
Why?
|
| Sirolimus | 1 | 2006 | 1545 | 0.010 |
Why?
|
| Hypertension | 2 | 1994 | 8626 | 0.010 |
Why?
|
| Zebrafish Proteins | 1 | 2005 | 1018 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 4348 | 0.010 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1979 | 170 | 0.010 |
Why?
|
| Periodicity | 1 | 1980 | 345 | 0.010 |
Why?
|
| Birds | 1 | 1979 | 165 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2016 | 22223 | 0.010 |
Why?
|
| Amino Acid Sequence | 3 | 2003 | 13400 | 0.010 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1979 | 175 | 0.010 |
Why?
|
| Insulin Antibodies | 1 | 1977 | 28 | 0.010 |
Why?
|
| Cytosol | 1 | 2001 | 885 | 0.010 |
Why?
|
| United States | 2 | 2016 | 72903 | 0.010 |
Why?
|
| Portacaval Shunt, Surgical | 1 | 1977 | 46 | 0.010 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2001 | 373 | 0.010 |
Why?
|
| Antibodies | 1 | 2006 | 2417 | 0.010 |
Why?
|
| Pituitary Gland | 2 | 1996 | 631 | 0.010 |
Why?
|
| Prognosis | 2 | 2010 | 29922 | 0.010 |
Why?
|
| Intestine, Small | 1 | 1984 | 1214 | 0.010 |
Why?
|
| Neural Crest | 1 | 1980 | 278 | 0.010 |
Why?
|
| Immunization, Passive | 1 | 1980 | 616 | 0.010 |
Why?
|
| Adrenergic beta-Agonists | 1 | 1979 | 345 | 0.010 |
Why?
|
| Pheochromocytoma | 1 | 1979 | 323 | 0.010 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 1998 | 287 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1977 | 340 | 0.010 |
Why?
|
| Thymus Gland | 1 | 2002 | 1261 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2014 | 13039 | 0.010 |
Why?
|
| Gastric Mucosa | 1 | 1979 | 602 | 0.010 |
Why?
|
| RNA Interference | 1 | 2005 | 2832 | 0.010 |
Why?
|
| Glomerular Filtration Rate | 1 | 2005 | 2233 | 0.010 |
Why?
|
| Morphogenesis | 1 | 2000 | 744 | 0.010 |
Why?
|
| Hepatic Encephalopathy | 1 | 1977 | 143 | 0.010 |
Why?
|
| Pro-Opiomelanocortin | 1 | 1996 | 140 | 0.010 |
Why?
|
| Contrast Media | 1 | 2009 | 5329 | 0.010 |
Why?
|
| Action Potentials | 1 | 2003 | 1838 | 0.010 |
Why?
|
| Glucose Transporter Type 1 | 1 | 1996 | 185 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 1982 | 1316 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1996 | 1140 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 1996 | 623 | 0.010 |
Why?
|
| Pituitary Neoplasms | 3 | 1989 | 1321 | 0.010 |
Why?
|
| Calcitonin | 1 | 1975 | 327 | 0.010 |
Why?
|
| Phosphorus | 1 | 1975 | 337 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1998 | 1884 | 0.010 |
Why?
|
| PC12 Cells | 1 | 1994 | 317 | 0.010 |
Why?
|
| Heart | 1 | 2007 | 4414 | 0.010 |
Why?
|
| Iodine Isotopes | 1 | 1973 | 79 | 0.010 |
Why?
|
| Dopamine | 1 | 1981 | 1582 | 0.010 |
Why?
|
| Absorption | 1 | 1973 | 242 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1979 | 1237 | 0.010 |
Why?
|
| Gonadotropins, Pituitary | 1 | 1973 | 70 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2001 | 2453 | 0.010 |
Why?
|
| Methods | 1 | 1973 | 1052 | 0.010 |
Why?
|
| Clomiphene | 1 | 1973 | 71 | 0.010 |
Why?
|
| Homeostasis | 2 | 1992 | 3336 | 0.010 |
Why?
|
| Cats | 1 | 1994 | 972 | 0.010 |
Why?
|
| Carbon Isotopes | 1 | 1973 | 451 | 0.010 |
Why?
|
| Hexokinase | 1 | 1992 | 125 | 0.010 |
Why?
|
| Neoplasms, Experimental | 3 | 1983 | 1229 | 0.010 |
Why?
|
| Magnesium | 1 | 1975 | 813 | 0.010 |
Why?
|
| Bicarbonates | 1 | 1973 | 293 | 0.010 |
Why?
|
| Pituitary Diseases | 1 | 1973 | 136 | 0.010 |
Why?
|
| Sulfur Radioisotopes | 1 | 1991 | 113 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2002 | 6309 | 0.010 |
Why?
|
| Intestines | 1 | 1980 | 1906 | 0.010 |
Why?
|
| Genotype | 1 | 2005 | 13024 | 0.010 |
Why?
|
| Autoradiography | 1 | 1991 | 723 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 1994 | 901 | 0.010 |
Why?
|
| DNA Probes | 1 | 1991 | 541 | 0.010 |
Why?
|
| Olfaction Disorders | 1 | 1973 | 223 | 0.010 |
Why?
|
| Manganese | 1 | 1973 | 395 | 0.010 |
Why?
|
| Species Specificity | 1 | 1994 | 2406 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1989 | 417 | 0.010 |
Why?
|
| Blood Proteins | 1 | 1975 | 1188 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2001 | 4520 | 0.010 |
Why?
|
| Drug Hypersensitivity | 1 | 1977 | 902 | 0.000 |
Why?
|
| Parathyroid Hormone | 1 | 1975 | 1789 | 0.000 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1989 | 1056 | 0.000 |
Why?
|
| Phenylhydrazines | 1 | 1968 | 28 | 0.000 |
Why?
|
| Clone Cells | 2 | 1983 | 1672 | 0.000 |
Why?
|
| Mitotic Index | 1 | 1988 | 159 | 0.000 |
Why?
|
| South Africa | 1 | 1993 | 1867 | 0.000 |
Why?
|
| Information Systems | 1 | 1989 | 400 | 0.000 |
Why?
|
| Algorithms | 1 | 2007 | 14071 | 0.000 |
Why?
|
| Sex Factors | 1 | 1981 | 10603 | 0.000 |
Why?
|
| Aspartic Acid | 1 | 1989 | 576 | 0.000 |
Why?
|
| Neoplasm Transplantation | 2 | 1980 | 2014 | 0.000 |
Why?
|
| Methionine | 1 | 1988 | 569 | 0.000 |
Why?
|
| Tryptophan | 2 | 1978 | 483 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1981 | 12976 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 2002 | 9249 | 0.000 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 1984 | 72 | 0.000 |
Why?
|
| Plasmids | 1 | 1989 | 2274 | 0.000 |
Why?
|
| Oxidation-Reduction | 1 | 1988 | 2218 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2009 | 36532 | 0.000 |
Why?
|
| Hexamethonium Compounds | 1 | 1980 | 23 | 0.000 |
Why?
|
| Neostigmine | 1 | 1980 | 67 | 0.000 |
Why?
|
| Amyloid beta-Peptides | 1 | 1994 | 3896 | 0.000 |
Why?
|
| Testis | 1 | 1983 | 780 | 0.000 |
Why?
|
| Receptors, Somatostatin | 1 | 1981 | 138 | 0.000 |
Why?
|
| Tetrodotoxin | 1 | 1980 | 244 | 0.000 |
Why?
|
| Pregnancy | 1 | 1981 | 30260 | 0.000 |
Why?
|
| Ovary | 1 | 1983 | 956 | 0.000 |
Why?
|
| Phentolamine | 1 | 1978 | 102 | 0.000 |
Why?
|
| Disorders of Sex Development | 1 | 1980 | 129 | 0.000 |
Why?
|
| Diazoxide | 1 | 1978 | 52 | 0.000 |
Why?
|
| Isoleucine | 1 | 1978 | 109 | 0.000 |
Why?
|
| Chromatography, Affinity | 1 | 1978 | 521 | 0.000 |
Why?
|
| Oxytocin | 1 | 1980 | 404 | 0.000 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 1980 | 540 | 0.000 |
Why?
|
| Isomerism | 1 | 1974 | 197 | 0.000 |
Why?
|
| Electric Stimulation | 1 | 1980 | 1735 | 0.000 |
Why?
|
| Cysteine | 1 | 1978 | 898 | 0.000 |
Why?
|
| Injections, Intravenous | 1 | 1974 | 1377 | 0.000 |
Why?
|
| Desensitization, Immunologic | 1 | 1977 | 544 | 0.000 |
Why?
|
| Spermatogenesis | 1 | 1973 | 260 | 0.000 |
Why?
|
| Immunoglobulin E | 1 | 1977 | 1481 | 0.000 |
Why?
|
| Hypopituitarism | 1 | 1973 | 254 | 0.000 |
Why?
|
| Hypogonadism | 1 | 1973 | 801 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1979 | 8532 | 0.000 |
Why?
|
| Testosterone | 1 | 1973 | 2494 | 0.000 |
Why?
|